Feng Ren is in the database as Chief Scientific Officer, Executive Director, and Co-CEO at Insilico Medicine.
Insilico's leadership page lists a Harvard chemistry PhD, 11 years in small-molecule drug discovery at GSK, and a senior R&D services role at Medicilon.
At Insilico, he is responsible for internal pipelines and external drug-discovery collaborations.